FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W73331317> ?p ?o ?g. }

• W73331317 endingPage "5" @default.
• W73331317 startingPage "191" @default.
• W73331317 abstract "The aim of this work was to assess the effect of recombinant human growth hormone (rhGH) on the kinetics of urea and creatinine and selected indices of dialysis adequacy in children with end-stage renal failure treated with peritoneal dialysis. We studied 24 children on peritoneal dialysis, including 10 children aged 9-15.7 years (mean age 12.5 years) treated with 1-1.1 IU/kg/week of rhGH administered daily for 6 months. The control group included 14 patients aged 5.4-18.3 years (mean age 12.6 years). Kinetic modelling of urea and creatinine using Adequest was performed in all patients at baseline and after 3 and 6 months of follow-up. Total dialysate and urinary excretion of urea and creatinine (tUE and tCE, mg/min), total urea and creatinine clearance (tUC and tCC, L/week), weekly Kt/V, normalized total weekly creatinine clearance (ntCC, L/week/1.73 m2), total body water (TBW, kg), and absolute and percent change of TBW (DTBW, kg, and D%TBW, respectively) were calculated. Albumin level was measured and diet composition was analysed in all patients. Insignificant decrease in Kt/V was found after 3 and 6 months of rhGH treatment despite stable values of tUC (45.3 +/- 15 L/week vs 45.6 +/- 15 L/week, p = NS). Serum creatinine increased from 7.38 +/- 1.52 to 9.26 +/- 2.98 mg/dL after 6 months of rhGH treatment. Significantly higher values of delta %TBW were found among treated patients compared to the control group (1.23 +/- 0.7 kh vs 0.57 +/- 0.7 kg, P < 0.05). delta TBW in patients treated with rhGH was significantly higher during months 0-3 compared to months 3-6 (0.85 +/- 0.6 kg and 0.38 +/- 0.17 kg, respectively, p < 0.05). No significant changes in ntCC, albumin concentration and diet composition were found.1. A trend to lower urea values in children treated with peritoneal dialysis was found after 3 months of rhGH treatment. Concomitant decrease in Kt/V may have resulted from increased TBW. 2. An increase in creatinine level was observed during rhGH treatment in children treated with peritoneal dialysis. Decrease in normalized total creatinine clearance (ntCC) and normalized dialysate creatinine clearance (ndCC) during rhGH treatment may have resulted from increased serum creatinine and not from decreased creatinine excretion. 3. Treatment with rhGH in children on peritoneal dialysis makes it difficult to interpret commonly used indices of dialysis adequacy such as Kt/V and ntCC." @default.
• W73331317 created "2016-06-24" @default.
• W73331317 creator A5039925052 @default.
• W73331317 creator A5049181118 @default.
• W73331317 creator A5058483463 @default.
• W73331317 creator A5063715594 @default.
• W73331317 creator A5064064986 @default.
• W73331317 creator A5086644632 @default.
• W73331317 creator A5086833725 @default.
• W73331317 date "2002-09-01" @default.
• W73331317 modified "2023-09-27" @default.
• W73331317 title "[The effect of recombinant human growth hormone on urea and creatinine kinetics and selected dialysis adequacy parameters in children with end-stage renal failure treated with peritoneal dialysis]." @default.
• W73331317 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12474568" @default.
• W73331317 hasPublicationYear "2002" @default.
• W73331317 type Work @default.
• W73331317 sameAs 73331317 @default.
• W73331317 citedByCount "0" @default.
• W73331317 crossrefType "journal-article" @default.
• W73331317 hasAuthorship W73331317A5039925052 @default.
• W73331317 hasAuthorship W73331317A5049181118 @default.
• W73331317 hasAuthorship W73331317A5058483463 @default.
• W73331317 hasAuthorship W73331317A5063715594 @default.
• W73331317 hasAuthorship W73331317A5064064986 @default.
• W73331317 hasAuthorship W73331317A5086644632 @default.
• W73331317 hasAuthorship W73331317A5086833725 @default.
• W73331317 hasConcept C126322002 @default.
• W73331317 hasConcept C126894567 @default.
• W73331317 hasConcept C134018914 @default.
• W73331317 hasConcept C159641895 @default.
• W73331317 hasConcept C185592680 @default.
• W73331317 hasConcept C2776399438 @default.
• W73331317 hasConcept C2779056158 @default.
• W73331317 hasConcept C2779978075 @default.
• W73331317 hasConcept C2780306776 @default.
• W73331317 hasConcept C2780365088 @default.
• W73331317 hasConcept C55493867 @default.
• W73331317 hasConcept C71924100 @default.
• W73331317 hasConceptScore W73331317C126322002 @default.
• W73331317 hasConceptScore W73331317C126894567 @default.
• W73331317 hasConceptScore W73331317C134018914 @default.
• W73331317 hasConceptScore W73331317C159641895 @default.
• W73331317 hasConceptScore W73331317C185592680 @default.
• W73331317 hasConceptScore W73331317C2776399438 @default.
• W73331317 hasConceptScore W73331317C2779056158 @default.
• W73331317 hasConceptScore W73331317C2779978075 @default.
• W73331317 hasConceptScore W73331317C2780306776 @default.
• W73331317 hasConceptScore W73331317C2780365088 @default.
• W73331317 hasConceptScore W73331317C55493867 @default.
• W73331317 hasConceptScore W73331317C71924100 @default.
• W73331317 hasIssue "75" @default.
• W73331317 hasLocation W733313171 @default.
• W73331317 hasOpenAccess W73331317 @default.
• W73331317 hasPrimaryLocation W733313171 @default.
• W73331317 hasRelatedWork W1941577772 @default.
• W73331317 hasRelatedWork W1980004663 @default.
• W73331317 hasRelatedWork W1990877999 @default.
• W73331317 hasRelatedWork W2034815122 @default.
• W73331317 hasRelatedWork W2150145104 @default.
• W73331317 hasRelatedWork W2154562099 @default.
• W73331317 hasRelatedWork W2354543897 @default.
• W73331317 hasRelatedWork W2374351533 @default.
• W73331317 hasRelatedWork W2439219185 @default.
• W73331317 hasRelatedWork W86176808 @default.
• W73331317 hasVolume "13" @default.
• W73331317 isParatext "false" @default.
• W73331317 isRetracted "false" @default.
• W73331317 magId "73331317" @default.
• W73331317 workType "article" @default.